Recruiting OBSERVATIONAL NCT06643741

Non-Invasive Preeclampsia Screening and Biobank

Collection of Pregnancy Outcome Data and Whole Blood Samples From Women Undergoing Non-Invasive Screening for Early, Preterm, and Term Preeclampsia

Sponsor: Laboratory Corporation of America

Conditions Preeclampsia (PE)

Updated 6 times since 2024 Last updated: Jan 21, 2026 Started: Feb 2, 2025 Primary completion: Jun 1, 2026 Completion: Jul 1, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Preeclampsia (PE), this trial is actively recruiting participants. The trial is conducted by Laboratory Corporation of America and has accumulated 6 data snapshots since 2025. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Feb 2026 — Present [monthly]

Recruiting
Jan 2026 — Feb 2026 [monthly]

Recruiting
Jul 2025 — Jan 2026 [monthly]

Recruiting
Jun 2025 — Jul 2025 [monthly]

Recruiting
Apr 2025 — Jun 2025 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Nov 2024 — Apr 2025 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Laboratory Corporation of America
Rutgers Robert Wood Johnson Medical School
Sequenom, Inc.

Data source: Sequenom, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Austin, United States , Boston, United States , Camden, United States , Chattanooga, United States , Danville, United States , Galveston, United States , Glendale, United States , Houston, United States , Livingston, United States , Metairie, United States and 8 more locations